Conversely, treatment with OMP or OMP-NS showed significant reductions in HMGB1, NLRP3, NF-κB, and proinflammatory cytokine levels, indicating potential in mitigating inflammation and promoting healing in gastric ulcers. This evidence concerns the gene NLRP3 and gastric ulcer.